title: Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein.
abstract: BACKGROUND
  Trichostatin A (TSA) is a well-characterized histone deacetylase (HDAC) inhibitor. TSA modifies the balance between HDAC and histone acetyltransferase activities that is important in chromatin remodeling and gene expression. Although several previous studies have demonstrated the role of TSA in regulation of estrogen receptor alpha (ERalpha), the precise mechanism by which TSA affects ERalpha activity remains unclear.
  
  
  METHODS
  Transient transfection was performed using the Welfect-EX Plus procedure. The mRNA expression was determined using RT-PCR. Protein expression and interaction were determined by western blotting and immunoprecipitation. The transfection of siRNAs was performed using the Oligofectamine reagent procedure.
  
  
  RESULTS
  TSA treatment increased acetylation of ERalpha in a dose-dependent manner. The TSA-induced acetylation of ERalpha was accompanied by an increased stability of ERalpha protein. Interestingly, TSA also increased the acetylation and the stability of p300 protein. Overexpression of p300 induced acetylation and stability of ERalpha by blocking ubiquitination. Knockdown of p300 by RNA interference decreased acetylation as well as the protein level of ERalpha, indicating that p300 mediated the TSA-induced stabilization of ERalpha.
  
  
  CONCLUSIONS
  We report that TSA enhanced acetylation as well as the stability of the ERalpha protein by modulating stability of p300. These results may provide the molecular basis for pharmacological functions of HDAC inhibitors in the treatment of human breast cancer.
authors.affiliation: College of Pharmacy, Seoul National University, San 56-1, Sillim-dong, Kwanak-gu, Seoul, Republic of Korea. kshsmj@greencross.com
authors.forename: Sung-Hye
authors.initials: SH
authors.lastname: Kim
authors.forename: Hyun-Jin
authors.initials: HJ
authors.lastname: Kang
authors.forename: Hyelin
authors.initials: H
authors.lastname: Na
authors.forename: Mi-Ock
authors.initials: MO
authors.lastname: Lee
mesh_terms: D000107:Acetylation / Q000187:drug effects; D015153:Blotting, Western; D045744:Cell Line, Tumor; D050881:E1A-Associated p300 Protein / Q000235:genetics / Q000378:metabolism*; D047628:Estrogen Receptor alpha / Q000235:genetics / Q000378:metabolism*; D006367:HeLa Cells; D056572:Histone Deacetylase Inhibitors / Q000494:pharmacology; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology*; D055550:Protein Stability / Q000187:drug effects; D034622:RNA Interference; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014162:Transfection
chemical_list: D047628:Estrogen Receptor alpha; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; C012589:trichostatin A; D050881:E1A-Associated p300 Protein; C494360:EP300 protein, human
references.citation: J Mammary Gland Biol Neoplasia. 1998 Jan;3(1):85-94
references.pmid: 10819507
references.citation: Clin Cancer Res. 2001 Apr;7(4):971-6
references.pmid: 11309348
references.citation: Mol Interv. 2003 Aug;3(5):281-92
references.pmid: 14993442
references.citation: J Biol Chem. 2000 Jul 7;275(27):20853-60
references.pmid: 10779504
references.citation: J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62
references.pmid: 16288118
references.citation: Oncogene. 2005 Jun 30;24(28):4531-9
references.pmid: 15806142
references.citation: Genes Dev. 2000 Jul 1;14(13):1553-77
references.pmid: 10887150
references.citation: Mol Endocrinol. 2005 Nov;19(11):2671-84
references.pmid: 15961505
references.citation: EMBO J. 2002 Nov 15;21(22):6236-45
references.pmid: 12426395
references.citation: J Cell Physiol. 1999 Jun;179(3):297-304
references.pmid: 10228948
references.citation: Lancet. 1998 May 16;351(9114):1451-67
references.pmid: 9605801
references.citation: Mol Cell Biol. 2004 Dec;24(24):10826-34
references.pmid: 15572685
references.citation: Oncogene. 2005 Jul 21;24(31):4894-907
references.pmid: 15870696
references.citation: Biochem Biophys Res Commun. 2005 Oct 14;336(1):274-80
references.pmid: 16126174
references.citation: Nat Rev Cancer. 2006 Jan;6(1):38-51
references.pmid: 16397526
references.citation: J Biol Chem. 2009 Jan 16;284(3):1343-52
references.pmid: 19015268
references.citation: J Biol Chem. 2001 Dec 7;276(49):45928-32
references.pmid: 11591713
references.citation: EMBO J. 2006 Mar 22;25(6):1231-41
references.pmid: 16511565
references.citation: Mol Endocrinol. 2005 Dec;19(12):2930-42
references.pmid: 16051668
references.citation: J Intern Med. 1999 Aug;246(2):133-8
references.pmid: 10447781
references.citation: Oncogene. 2007 Aug 13;26(37):5310-8
references.pmid: 17694074
references.citation: Int J Cancer. 2003 Nov 10;107(3):353-8
references.pmid: 14506733
references.citation: Biochem Biophys Res Commun. 2006 Sep 29;348(3):799-806
references.pmid: 16904069
references.citation: Mol Endocrinol. 2006 Jul;20(7):1479-93
references.pmid: 16497729
references.citation: Mol Cell. 2007 Oct 12;28(1):91-106
references.pmid: 17936707
references.citation: Clin Cancer Res. 2004 Dec 1;10(23):8094-104
references.pmid: 15585645
references.citation: Biochemistry. 2001 Dec 25;40(51):15456-63
references.pmid: 11747420
references.citation: FEBS Lett. 2009 Jan 5;583(1):55-60
references.pmid: 19071119
references.citation: Circulation. 2000 Apr 18;101(15):1792-8
references.pmid: 10769279
references.citation: IUBMB Life. 2005 Mar;57(3):137-49
references.pmid: 16036576
references.citation: Mol Endocrinol. 2008 Jul;22(7):1535-51
references.pmid: 18388150
references.citation: J Biol Chem. 1994 Feb 11;269(6):4458-66
references.pmid: 8308015
references.citation: Trends Endocrinol Metab. 1991 Mar-Apr;2(2):72-6
references.pmid: 18411169
references.citation: Mol Endocrinol. 2006 Dec;20(12):3120-32
references.pmid: 16945990
references.citation: Gene. 2005 Dec 19;363:15-23
references.pmid: 16289629
references.citation: J Biol Chem. 2005 Dec 16;280(50):41537-45
references.pmid: 16219772
references.citation: Nat Struct Mol Biol. 2004 Apr;11(4):308-15
references.pmid: 15004546
references.citation: J Biol Chem. 2001 May 25;276(21):18375-83
references.pmid: 11279135
references.citation: Cancer Res. 2007 Mar 1;67(5):2256-2264
references.pmid: 17332356
references.citation: Breast Cancer Res. 2004;6(1):39-52
references.pmid: 14680484
references.citation: J Biol Chem. 2005 Jun 10;280(23):21797-803
references.pmid: 15831498